New York Life Investment Management LLC Has $3.88 Million Holdings in Mettler-Toledo International Inc. (NYSE:MTD)

New York Life Investment Management LLC increased its position in shares of Mettler-Toledo International Inc. (NYSE:MTD) by 0.6% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 3,167 shares of the medical instruments supplier’s stock after purchasing an additional 20 shares during the period. New York Life Investment Management LLC’s holdings in Mettler-Toledo International were worth $3,875,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Blue Trust Inc. grew its position in shares of Mettler-Toledo International by 242.9% in the 3rd quarter. Blue Trust Inc. now owns 24 shares of the medical instruments supplier’s stock valued at $34,000 after acquiring an additional 17 shares during the period. Ashton Thomas Securities LLC acquired a new stake in Mettler-Toledo International in the 3rd quarter valued at about $37,000. Whipplewood Advisors LLC bought a new position in Mettler-Toledo International during the fourth quarter worth about $54,000. Sound Income Strategies LLC increased its position in Mettler-Toledo International by 4,500.0% during the fourth quarter. Sound Income Strategies LLC now owns 46 shares of the medical instruments supplier’s stock worth $56,000 after buying an additional 45 shares during the last quarter. Finally, Huntington National Bank raised its stake in Mettler-Toledo International by 20.0% in the third quarter. Huntington National Bank now owns 54 shares of the medical instruments supplier’s stock valued at $81,000 after buying an additional 9 shares during the period. 95.07% of the stock is currently owned by institutional investors and hedge funds.

Mettler-Toledo International Stock Up 1.4 %

Shares of Mettler-Toledo International stock opened at $1,271.44 on Friday. The stock has a market capitalization of $26.59 billion, a price-to-earnings ratio of 31.37, a price-to-earnings-growth ratio of 3.30 and a beta of 1.13. Mettler-Toledo International Inc. has a twelve month low of $1,142.91 and a twelve month high of $1,546.93. The company has a 50-day simple moving average of $1,291.19 and a two-hundred day simple moving average of $1,329.59.

Mettler-Toledo International (NYSE:MTD) last issued its quarterly earnings results on Thursday, February 13th. The medical instruments supplier reported $12.41 earnings per share (EPS) for the quarter, beating the consensus estimate of $11.76 by $0.65. Mettler-Toledo International had a negative return on equity of 591.54% and a net margin of 22.29%. On average, sell-side analysts anticipate that Mettler-Toledo International Inc. will post 42.71 earnings per share for the current fiscal year.

Insider Transactions at Mettler-Toledo International

In other news, insider Gerry Keller sold 600 shares of the business’s stock in a transaction that occurred on Monday, February 10th. The shares were sold at an average price of $1,351.34, for a total value of $810,804.00. Following the completion of the transaction, the insider now directly owns 6 shares in the company, valued at approximately $8,108.04. The trade was a 99.01 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Christian Magloth sold 790 shares of the stock in a transaction that occurred on Monday, February 24th. The stock was sold at an average price of $1,313.69, for a total transaction of $1,037,815.10. Following the sale, the insider now owns 734 shares in the company, valued at $964,248.46. This represents a 51.84 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 1,530 shares of company stock valued at $2,024,192. 1.94% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

MTD has been the subject of several research analyst reports. Citigroup upgraded Mettler-Toledo International from a “sell” rating to a “neutral” rating and lifted their target price for the stock from $1,200.00 to $1,300.00 in a research note on Wednesday, December 11th. Stifel Nicolaus reduced their price objective on shares of Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating for the company in a research report on Monday, November 11th. Evercore ISI increased their price objective on shares of Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the company an “outperform” rating in a research report on Monday, February 10th. Robert W. Baird raised their target price on shares of Mettler-Toledo International from $1,362.00 to $1,369.00 and gave the stock a “neutral” rating in a research note on Monday, February 10th. Finally, Wolfe Research initiated coverage on shares of Mettler-Toledo International in a research note on Friday, December 13th. They issued a “peer perform” rating on the stock. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and three have given a buy rating to the company. According to MarketBeat.com, Mettler-Toledo International currently has an average rating of “Hold” and a consensus target price of $1,368.00.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.